Afatinib

• Description:

  Afatinib is an orally bioavailable anilino-quinazoline derivative and inhibitor of the receptor tyrosine kinase (RTK) epidermal growth factor receptor (ErbB; EGFR) family, with antineoplastic activity.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  485.94

• Molecular Formula:

  C24H25ClFN5O3

• Notes:

  Research use only, not for human use.

• Receptor:

  EGFR (L858R) | EGFR (L858R/T790M) | EGFR (wt) | HER2

• CAS Number:

  439081-18-2